Wuhan Super Pharmaceutical Co., Ltd. - China

Welcome to

Wuhan Super Pharmaceutical Co., Ltd.

Free Member

Wuhan Super Pharmaceutical Co., Ltd.
China

Home
Company Info
Contact Us
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Ms. Joyce Helin

E-mail:

Send Message

Instant Messaging:

Mobile Number:

Phone Number:

Address:

Wuhan, Hubei
China

Average User Review

There is no review for this company - Write a review

Registration Date:

Jul. 4, 2013

Last Updated:

Jul. 6, 2013

Business Nature:

Manufacturing of Chemicals category

Want to contact this company?

Add to Basket or Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Wuhan Super Pharmaceutical Co., Ltd. is a large pharmaceutical manufacturer in China.The head office locates in the beautiful city of Wuhan. Our factory covers an area of 10000 square meters.There are two production lines equipped with advanced apparatus.
Our business scope comprises research, development, manufacturing, and sales of pharmaceuticals.We have an R& D team of 20, since founded in 2002, our company has developed 40 patent products.Also, we have successfully marketed our products into more than 20 countries all over the world.
With 11 yearsâ € ™ experience in this field, we are professional in the production and supply of pharmaceuticals, especially steroid hormones and male enhancers.Our belief is quality is life.Based on this belief we have built strict QA& QC systems, and our company is ISO 9001 certified.In the past years, we have made great effort in fast shipping and safe transportation, and now we have a perfect mechanism to manage the risk of clients in international business.
The development of our company is based on integrity, creativity, and mutual benefit.Our dream is to supply the world with best quality and service. Sincerely hope we can establish business relationship in the future.

I am familiar with this company and want to review it.

You have [3] new inquiries.